Literature DB >> 16145716

Efficient allocation of resources to prevent HIV infection among injection drug users: the Prevention Point Philadelphia (PPP) needle exchange program.

Zoë K Harris1.   

Abstract

The objective of this study is to determine the allocation of resources within a multi-site needle exchange program (NEP) that achieves the largest possible reduction in new HIV infections at minimum cost. We present a model that relates the number of injection drug user (IDU) clients and the number of syringes exchanged per client to both the costs of the NEP and the expected reduction in HIV infections per unit time. We show that cost-effective allocation within a multi-site NEP requires that sites be located where the density of IDUs is highest, and that the number of syringes exchanged per client be equal across sites. We apply these optimal allocation rules to a specific multi-site needle exchange program, Prevention Point Philadelphia (PPP). This NEP, we find, needs to add 2 or 3 new sites in neighborhoods with the highest density of IDU AIDS cases, and to increase its total IDU client base by about 28%, from approximately 6400 to 8200 IDU clients. The case-study NEP also needs to increase its hours of operation at two existing sites, where the number of needles distributed per client is currently sub-optimal, by 50%. At the optimal allocation, the estimated cost per case of HIV averted would be dollar 2800 (range dollar 2300-dollar 4200). Such a favorable cost-effectiveness ratio derives primarily from PPP's low marginal costs per distributed needle. Copyright 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2006        PMID: 16145716     DOI: 10.1002/hec.1021

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  6 in total

1.  The cost-effectiveness of a modestly effective HIV vaccine in the United States.

Authors:  Elisa F Long; Douglas K Owens
Journal:  Vaccine       Date:  2011-04-19       Impact factor: 3.641

2.  The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States.

Authors:  Elisa F Long; Margaret L Brandeau; Douglas K Owens
Journal:  Ann Intern Med       Date:  2010-12-21       Impact factor: 25.391

3.  Potential population health outcomes and expenditures of HIV vaccination strategies in the United States.

Authors:  Elisa F Long; Margaret L Brandeau; Douglas K Owens
Journal:  Vaccine       Date:  2009-07-08       Impact factor: 3.641

4.  Ability to access community-based needle-syringe programs and injecting behaviors among drug users: a cross-sectional study in Hunan Province, China.

Authors:  Lei Zhang; Xi Chen; Jun Zheng; Junshi Zhao; Jun Jing; Jun Zhang; Eric P F Chow; David P Wilson
Journal:  Harm Reduct J       Date:  2013-05-07

5.  Needle and syringe programs in Yunnan, China yield health and financial return.

Authors:  Lei Zhang; Lorraine Yap; Zhuang Xun; Zunyou Wu; David P Wilson
Journal:  BMC Public Health       Date:  2011-04-21       Impact factor: 3.295

6.  Cost-effectiveness analysis of brief and expanded evidence-based risk reduction interventions for HIV-infected people who inject drugs in the United States.

Authors:  Dahye L Song; Frederick L Altice; Michael M Copenhaver; Elisa F Long
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.